Jun 10, 2026 | Corporate, Media
Persei vivarium advances an integrated solution for the continuous follow-up of oncology patients by Persei vivarium, June 10, 2026 The rising incidence of cancer, increasing healthcare system pressure, and the growing complexity of treatments are transforming cancer...
Apr 22, 2026 | Corporate, Media
GETECCU recognized as a national reference in Inflammatory Bowel Disease (IBD), driven by the ENEIDA registry by Ana-Díaz Roncero, April 22, 2026 Recently, the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) has published an overview of its...
Feb 25, 2026 | Corporate, Media
Persei vivarium promotes UR-CARE and E-QUALITY at ECCO’26, the leading international IBD congress by Patricia Domínguez, February 25, 2026 ECCO’26, this year’s edition of the leading international congress on Inflammatory Bowel Disease (IBD), took place from February...
Nov 5, 2025 | Certifications, Corporate, Media
Persei vivarium renews its B Corp certification, reaffirming its commitment to a positive impact on health and people by Patricia Domínguez, November, 5, 2025 Persei vivarium, which first obtained B Corp Certification in 2022, has successfully completed its...
Oct 15, 2025 | Corporate, Media
Persei vivarium among the “World’s Top HealthTech Companies” of 2025 by Ana Díaz-Roncero, October 15, 2025 Persei vivarium has been included in the ranking of the “World’s Top HealthTech Companies 2025”, a global reference publication that recognizes the most...
Sep 30, 2025 | Corporate, Media
Persei vivarium boosts its growth by joining Zelenza Group by Persei vivarium, October 1, 2025 Persei vivarium is joining Zelenza, a leading Spanish technology group in Managed Services, Engineering, and Security, forging an alliance that will enhance the development...
